Department of Applied Biochemistry
Henry Fechner has not added Biography.
If you are Henry Fechner and would like to personalize this page please email our Author Liaison for assistance.
Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism.
Circulation Feb, 2003 | Pubmed ID: 12591759
Molecular genetic and expression analysis of alpha-tocopherol transfer protein mRNA in German shepherd dogs with degenerative myelopathy.
Berliner und Munchener tierarztliche Wochenschrift Jan-Feb, 2003 | Pubmed ID: 12592926
Regulation of human factor IX expression using doxycycline-inducible gene expression system.
Thrombosis and haemostasis Sep, 2003 | Pubmed ID: 12958607
Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.
The Journal of investigative dermatology Jan, 2005 | Pubmed ID: 15654977
Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses.
Molecular therapy : the journal of the American Society of Gene Therapy Apr, 2005 | Pubmed ID: 15771959
An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy.
Journal of molecular medicine (Berlin, Germany) Mar, 2006 | Pubmed ID: 16437213
Gene therapy for gastric cancer: is it promising?
World journal of gastroenterology Jan, 2006 | Pubmed ID: 16489636
A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication.
Journal of biotechnology Jan, 2007 | Pubmed ID: 17083991
Dimethyl sulfoxide enhances doxycycline-dependent protein expression in Tet-On cells.
BioTechniques Mar, 2007 | Pubmed ID: 17390537
Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma.
Experimental dermatology Jan, 2008 | Pubmed ID: 18095940
Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
European heart journal May, 2008 | Pubmed ID: 18390538
Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy.
Journal of molecular medicine (Berlin, Germany) Sep, 2008 | Pubmed ID: 18548221
Inhibition of picornaviruses by means of RNA interference.
Nucleic acids symposium series (2004) , 2008 | Pubmed ID: 18776254
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.
Circulation Mar, 2009 | Pubmed ID: 19237664
Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.
Antiviral research Sep, 2009 | Pubmed ID: 19591879
Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus.
Experimental dermatology Aug, 2010 | Pubmed ID: 19725869
Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38.
International journal of cancer Jun, 2010 | Pubmed ID: 19739070
Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
Circulation Dec, 2009 | Pubmed ID: 19933937
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.
Cardiovascular research Jun, 2010 | Pubmed ID: 20176815
Rapid construction of adeno-associated virus vectors expressing multiple short hairpin RNAs with high antiviral activity against echovirus 30.
Oligonucleotides Aug, 2010 | Pubmed ID: 20649454
Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
Antiviral research Oct, 2010 | Pubmed ID: 20708037
Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
Human gene therapy Apr, 2011 | Pubmed ID: 20977303
Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator.
Circulation Dec, 2010 | Pubmed ID: 21135363
Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV).
Vaccine Feb, 2011 | Pubmed ID: 21195079
Decreased cardiac SERCA2 expression, SR Ca uptake, and contractile function in hypothyroidism are attenuated in SERCA2 overexpressing transgenic rats.
American journal of physiology. Heart and circulatory physiology Mar, 2011 | Pubmed ID: 21217071
Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.
Virology Mar, 2011 | Pubmed ID: 21236463
Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
Journal of virology Dec, 2011 | Pubmed ID: 21976640
Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.
Molecules (Basel, Switzerland) Oct, 2011 | Pubmed ID: 21989310
Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression.
Journal of virology May, 2012 | Pubmed ID: 22357277
Application of Mutated miR-206 Target Sites Enables Skeletal Muscle-specific Silencing of Transgene Expression of Cardiotropic AAV9 Vectors.
Molecular therapy : the journal of the American Society of Gene Therapy Feb, 2013 | Pubmed ID: 23439498
Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.
Virus research Sep, 2013 | Pubmed ID: 23770153
A novel method for the quantification of adeno-associated virus vectors for RNA interference applications using quantitative polymerase chain reaction and purified genomic adeno-associated virus DNA as a standard.
Human gene therapy methods Dec, 2013 | Pubmed ID: 23987130
A novel artificial microRNA expressing AAV vector for phospholamban silencing in cardiomyocytes improves Ca2+ uptake into the sarcoplasmic reticulum.
PloS one , 2014 | Pubmed ID: 24670775
Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.
Journal of virology Jul, 2014 | Pubmed ID: 24741103
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.
Journal of virology Jul, 2014 | Pubmed ID: 24807719
Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
The Journal of infectious diseases Feb, 2015 | Pubmed ID: 25193982
Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.
The Journal of infectious diseases Oct, 2015 | Pubmed ID: 25805750
Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir.
Antiviral research Aug, 2015 | Pubmed ID: 26026665
Use of a three-dimensional humanized liver model for the study of viral gene vectors.
Journal of biotechnology Oct, 2015 | Pubmed ID: 26356676
Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.
Future medicinal chemistry , 2015 | Pubmed ID: 26381598
The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection.
Journal of virology Jun, 2016 | Pubmed ID: 27030267
Biological antivirals for treatment of adenovirus infections.
Antiviral therapy Apr, 2016 | Pubmed ID: 27032991
MicroRNA-regulated viral vectors for gene therapy.
World journal of experimental medicine May, 2016 | Pubmed ID: 27226955
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved